drugset / Trial / NCT00092976
Study Evaluating ReFacto® in Hemophilia A Undergoing Major Surgery
Non-randomizedSingle-groupOpen-labelTreatment
Summary
The primary objective of this clinical research study is to evaluate the safety and efficacy of ReFacto in subjects with hemophilia A undergoing major surgery monitored using the chromogenic substrate assay at the local laboratory.
Timeline
- Start
- 2003-02
- Primary completion
- —
- Completion
- 2007-07
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Moroctocog alfa | Protein / enzyme biologic | — | — |